Sensory Feedback Stimulation for Amputees
Trial Summary
What is the purpose of this trial?
The purpose of this study is to evaluate the effectiveness of providing sensation of the missing limb to individuals with lower limb loss, including above and below knee amputees. The approach involves delivering small electrical currents directly to remaining nerves via implanted stimulating electrodes. These small electrical currents cause the nerves to generate signals that are then transferred to your brain similar to how information about the foot and lower limb used to be transferred to your brain prior to the amputation. Individuals also have the option to have recording electrodes implanted within muscles of the lower limb(s) in an attempt to develop a motor controller that would enable the user to have intuitive control of a robotic prosthetic leg.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the study team or your doctor.
What data supports the effectiveness of the treatment Multi contact electrode implant for sensory feedback stimulation in amputees?
Research shows that implanted nerve interfaces can provide stable, natural touch sensations for amputees, improving their ability to control prosthetic devices and manipulate objects. Additionally, similar treatments have been shown to enhance mobility, reduce phantom limb pain, and increase confidence in using prosthetic limbs.12345
Is sensory feedback stimulation for amputees generally safe for humans?
Research shows that sensory feedback stimulation, including methods like implanted nerve interfaces and transcutaneous electrical nerve stimulation (TENS), has been used safely in humans. Studies report stable and natural touch sensations without adverse effects over long periods, suggesting it is generally safe for human use.24567
How does the Multi contact electrode implant treatment for amputees differ from other treatments?
The Multi contact electrode implant treatment is unique because it uses implanted electrodes to provide natural touch sensations directly to the nerves, allowing amputees to feel different types of touch on their phantom hand. This approach offers stable, long-term sensory feedback, unlike other treatments that may not provide direct or natural sensation.12589
Research Team
Ronald Triolo, PhD
Principal Investigator
Louis Stokes VA Medical Center
Eligibility Criteria
This trial is for adults over 18 with lower limb amputations who may use prostheses for standing or walking. They must have good nerve function in the remaining limb, stable health, and no severe skin issues. Excluded are those with chronic infections, obesity (BMI > 35), uncontrolled diabetes, balance disorders, significant mental health issues, or a need for MRI during the study.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Surgical Implantation
Electrodes are surgically implanted on nerves and muscles of the residual limb
Experimental Testing
Participants receive electrical stimulation and engage in functional tasks with the sensory neuroprosthesis
Follow-up
Participants are monitored for safety and effectiveness after the experimental testing
Treatment Details
Interventions
- Multi contact electrode implant (Multi-contact Electrode)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Louis Stokes VA Medical Center
Lead Sponsor
United States Department of Defense
Collaborator
Pete Hegseth
United States Department of Defense
Chief Executive Officer
Bachelor's degree in Political Science from Princeton University, JD from Harvard Law School
Lisa Hershman
United States Department of Defense
Chief Medical Officer since 2021
MD from Uniformed Services University of the Health Sciences
Case Western Reserve University
Collaborator
Eric W. Kaler
Case Western Reserve University
Chief Executive Officer since 2021
PhD in Chemical Engineering from the University of Minnesota
Stanton L. Gerson
Case Western Reserve University
Chief Medical Officer since 2020
MD from Harvard Medical School